SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-24-049086
Filing Date
2024-04-19
Accepted
2024-04-19 07:00:16
Documents
5
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm242864-1_pre14a.htm PRE 14A 744273
2 GRAPHIC lg_entradatherapeutic-4c.jpg GRAPHIC 15939
3 GRAPHIC px_24entradapage01-4c.jpg GRAPHIC 137236
4 GRAPHIC px_24entradapage02-bw.jpg GRAPHIC 156970
5 GRAPHIC px_24entradapage03-bw.jpg GRAPHIC 188989
  Complete submission text file 0001104659-24-049086.txt   1339062
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40969 | Film No.: 24855597
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)